Alemtuzumab improves quality of life in relapsing-remitting multiple sclerosis patients who relapsed on prior therapy: 3-year follow-up of CARE-MS II

Affiliation auteursAffiliation ok
TitreAlemtuzumab improves quality of life in relapsing-remitting multiple sclerosis patients who relapsed on prior therapy: 3-year follow-up of CARE-MS II
Type de publicationJournal Article
Year of Publication2014
AuteursMoreau T., Margolin D.H, Kasten L., Singer B., Investigators CARE-MSII
JournalMULTIPLE SCLEROSIS JOURNAL
Volume20
Pagination86
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN1352-4585